Aubry K, Sauvage J P, Puyraud S
CHU de Limoges, Service d'ORL, France.
Rev Laryngol Otol Rhinol (Bord). 2006;127(3):145-9.
Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period.
is to discuss our clinical cases and review the literature.
Three cases of middle ear amphicrine tumour were reviewed.
During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment.
Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.
两性细胞瘤是一种极其罕见的中耳肿瘤。我们报告20年间收治的3例病例。
是讨论我们的临床病例并回顾相关文献。
回顾3例中耳两性细胞瘤病例。
在1986年至2006年的10年间,我们科室收治了3例中耳两性细胞瘤患者(2例男性,1例女性)。所有3例患者的主要症状均为听力丧失。两性细胞瘤通过病理标本的免疫组织学检查确诊。鉴别诊断可能困难,1例患者最初被误诊为腺癌并接受了放疗。该患者放疗后两年死于脑霉菌病。另外2例患者在治疗后8年和9年无复发迹象。
从历史上看,中耳两性细胞瘤与腺癌的鉴别诊断一直非常困难。类癌肿瘤被认为是两性细胞瘤的一种更具侵袭性的形式。肿瘤通过局部区域浸润进展。手术完整切除并长期随访是首选治疗方法。